Health - Aug 10
It is essential to assess the severity of multiple sclerosis (MS) in order to choose appropriate therapeutic measures, but this cannot be reliably done using existing methods. A MedUni Vienna study now shows for the first time that the retina can be used as a prognostic marker. Analyses revealed that retinal layer thinning as a result of an MS relapse predicts the severity of future relapses and, hence, the likelihood of disability. The results of the study have now been published in Neurology.
Health - Aug 9
Health

An Austrian study led by MedUni Vienna showed that active brain metastases in breast cancer patients are partially or even completely regressed by a novel class of drug. This is a chemical conjugate of an antibody and a chemotherapy drug that, according to current findings, opens up a completely new avenue in oncological research and targeted therapy. The study results were published in the top journal "Nature Medicine" and are considered ground-breaking in the treatment of brain metastases, a dreaded complication of cancer.

Environment - Aug 5
Environment

The different geographic and climatic regions from which ragweed pollen originates, as well as the degree of environmental pollution, may influence the severity of allergic reactions such as hay fever and asthma. Pollen from plants in different areas exhibit different levels of aggressiveness. This is the conclusion reached by an inter-university study team led by MedUni Vienna and involving the University of Vienna and the University of Natural Resources and Applied Life Sciences. The study was recently published in the journal "Frontiers in Allergy".

Computer Science - Aug 9

International IT security research teams headed by Daniel Gruss of TU Graz have released information on two new forms of cyberattack that exploit hardware. Reliable, bug-free computer hardware provides the foundation for secure software.

Life Sciences - Aug 2

A multidisciplinary study led by Vanja Nagy (LBI-RUD/CeMM/Medical University of Vienna) and Josef Penninger (UBC/IMBA) characterized a novel gene, known as FIBCD1, to be likely causative of a new and rare neurodevelopmental disorder. Using data from two young patients with neurological symptoms, the researchers from both groups found evidence of a novel function for the FIBCD1 gene in the brain, and a potentially pivotal role in diseases such as autism, ADHD, schizophrenia, and neurodegenerative disorders including Alzheimer-s. The study makes an important contribution to the understanding of the extracellular matrix in the brain and its associated neurological diseases.

Selected Job Offers
Computer Science - 09.08
Postdoc at the Hilti Chair for Data & Application Security 75% (m/f/d) University of Liechtenstein
Economics/Business - 02.08
Professor*in an der Fakultät für Technik (m/w/d) Hochschule Pforzheim
Economics/Business - 15.07
Studiengangsmanager Weiterbildungsprogramme (m/w/d) 60%-100% Universität Liechtenstein
Employers of the Week